Q4 2025 Siemens Healthineers AG Earnings Call Transcript
Key Points
- Siemens Healthineers AG (SMMNY) achieved growth at the upper end of their outlook range, with all regions except China showing positive results.
- The company reported a strong book-to-bill ratio of 1.14 for fiscal year 2025, indicating healthy demand.
- Imaging, Varian, and Advanced Therapies segments collectively increased revenue by almost 8%, with Imaging showing continued margin expansion.
- The company successfully implemented a transformation program in diagnostics, leading to improved profitability despite challenges in China.
- Siemens Healthineers AG (SMMNY) proposed a dividend increase to EUR1, reflecting confidence in their financial performance.
- Revenue in China remained flat, with no signs of a sustained market recovery, impacting the company's overall outlook.
- Tariffs significantly affected margins, with a reported EUR200 million impact in fiscal year 2025 and an expected EUR400 million in 2026.
- The company anticipates macroeconomic challenges, including a strong Euro and tariffs, to negatively impact earnings per share in fiscal year 2026.
- Diagnostics segment faced flat revenue growth due to volume-based procurement in China, expected to continue impacting results into 2026.
- The company expects revenue growth in Q1 2026 to be below their outlook range of 5% to 6%, with margins also expected to be below the prior year quarter due to tariffs and foreign exchange.
As a reminder, this conference is being recorded. Before we begin, I would like to draw your attention to the safe harbor statement on page 2 of the Siemens Healthineers presentation. This conference call may include forward-looking statements. These statements are based on the company's current expectations and certain assumptions and are therefore subject to certain risks and uncertainties.
At this time, I would like to turn the call over to your house today, Mr. Marc Koebernick, Head of Investor Relations. Please go ahead, sir.
Thank you, operator. Good morning and welcome to our fourth quarter 2026 earnings -- '25 earnings call. It's great that you are tuning in again today. At 7:00 AM we published our Q4 results, and the materials for today's results are all available on the IR section of the Siemens Healthineers website. It is common practice that our CEO, Bernd Montag; and our CFO, Jochen Schmitz will be presenting to you what you need to know about our Q4 of fiscal '25 and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
